Akebia Therapeutics, Inc.
Ticker: 1517022
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Q3 FY24 | Q2 FY24 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 36.90-24.9% | 49.13-8.2% | 53.54-8.9% | 58.77-5.9% | 62.47+8.9% | 57.34+53.2% | 37.43-14.2% | 43.65 |
| Total Income | 36.90-24.9% | 49.13-8.2% | 53.54-8.9% | 58.77-5.9% | 62.47+8.9% | 57.34+53.2% | 37.43-14.2% | 43.65 |
| EXPENSES | ||||||||
| Expenditure | 48.37-12.8% | 55.45-4.8% | 58.24+7.2% | 54.32+12.3% | 48.38+10.4% | 43.82-12.2% | 49.93-4.7% | 52.37 |
| Tax | 0.18+157.1% | 0.07-46.2% | 0.13-79.0% | 0.62 | — | — | — | — |
| PROFIT | ||||||||
| PBT | -14.18-60.4% | -8.84+1.0% | -8.93-869.8% | 1.16+364.0% | 0.25-95.9% | 6.11+130.5% | -20.04-133.6% | -8.58 |
| Net Profit | -14.35-61.1% | -8.91+1.5% | -9.05-1775.9% | 0.54+116.0% | 0.25-95.9% | 6.11+130.5% | -20.04-133.6% | -8.58 |
| KEY METRICS | ||||||||
| OPM % | -31.06%-18.18pp | -12.88%-4.11pp | -8.77%-16.34pp | 7.57%-14.98pp | 22.55%-1.02pp | 23.57%+56.98pp | -33.41%-13.42pp | -19.99% |
| NPM % | -38.90%-20.76pp | -18.13%-1.22pp | -16.91%-17.83pp | 0.92%+0.52pp | 0.40%-10.27pp | 10.66%+64.20pp | -53.54%-33.88pp | -19.66% |
| EPS | -0.05-66.7% | -0.03+0.0% | -0.03 | 0.00 | 0.00-100.0% | 0.03+130.0% | -0.10-150.0% | -0.04 |
Corporate Events
Board MeetingAKBA
20266Nov
Board Meeting
Nicholas Grund, Senior Vice President and Chief Commercial O…
SEC Filing ↗ Board MeetingAKBA
202617Jun
Board Meeting
2026 Annual Meeting of Stockholders to elect directors, appr…
SEC Filing ↗